UBS Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,427
| Closed | -$8K | – | 7517 |
|
|
2019
Q4 | $8K | Sell |
2,427
-8,826
| -78% | -$29.1K | ﹤0.01% | 6348 |
|
|
2019
Q3 | $34K | Buy |
11,253
+10,253
| +1,025% | +$31K | ﹤0.01% | 5466 |
|
|
2019
Q2 | $2K | Sell |
1,000
-1,413
| -59% | -$2.83K | ﹤0.01% | 6795 |
|
|
2019
Q1 | $9K | Sell |
2,413
-1,730,584
| -100% | -$6.45M | ﹤0.01% | 6074 |
|
|
2018
Q4 | $6.22M | Buy |
1,732,997
+1,725,874
| +24,230% | +$6.2M | ﹤0.01% | 1548 |
|
|
2018
Q3 | $41K | Buy |
7,123
+2,187
| +44% | +$12.6K | ﹤0.01% | 5415 |
|
|
2018
Q2 | $25K | Buy |
4,936
+3,936
| +394% | +$19.9K | ﹤0.01% | 5636 |
|
|
2018
Q1 | $5K | Sell |
1,000
-297
| -23% | -$1.49K | ﹤0.01% | 6380 |
|
|
2017
Q4 | $8K | Sell |
1,297
-4,670
| -78% | -$28.8K | ﹤0.01% | 6214 |
|
|
2017
Q3 | $34K | Buy |
5,967
+4,967
| +497% | +$28.3K | ﹤0.01% | 5189 |
|
|
2017
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 6207 |
|
|
2017
Q1 | $5K | Sell |
1,000
-615
| -38% | -$3.08K | ﹤0.01% | 6095 |
|
|
2016
Q4 | $18K | Sell |
1,615
-1,014
| -39% | -$11.3K | ﹤0.01% | 5645 |
|
|
2016
Q3 | $25K | Buy |
2,629
+1,152
| +78% | +$11K | ﹤0.01% | 5229 |
|
|
2016
Q2 | $9K | Sell |
1,477
-1,834
| -55% | -$11.2K | ﹤0.01% | 5969 |
|
|
2016
Q1 | $22K | Buy |
3,311
+1,536
| +87% | +$10.2K | ﹤0.01% | 5317 |
|
|
2015
Q4 | $15K | Buy |
1,775
+333
| +23% | +$2.81K | ﹤0.01% | 5783 |
|
|
2015
Q3 | $11K | Sell |
1,442
-8,210
| -85% | -$62.6K | ﹤0.01% | 5882 |
|
|
2015
Q2 | $99K | Buy |
9,652
+6,795
| +238% | +$69.7K | ﹤0.01% | 4309 |
|
|
2015
Q1 | $26K | Buy |
+2,857
| New | +$26K | ﹤0.01% | 5173 |
|